Biodiversity provides critical support for drug discovery and the availability of medicinal resources. A significant proportion of drugs are derived, directly or indirectly, from biological sources: at least 50% of the pharmaceutical compounds on the US market are derived from plants, animals, and micro-organisms, while about 80% of the world population depends on medicines from nature (used in either modern or traditional medical practice) for primary healthcare. Only a tiny fraction of wild species has been investigated for medical potential. Biodiversity has been critical to advances throughout the field of bionics. Evidence from market analysis and biodiversity science indicates that the decline in output from the pharmaceutical sector since the mid-1980s can be attributed to a move away from natural product exploration ("bioprospecting") in favor of genomics and synthetic chemistry, indeed claims about the value of undiscovered pharmaceuticals may not provide enough incentive for companies in free markets to search for them because of the high cost of development; meanwhile, natural products have a long history of supporting significant economic and health innovation. Marine ecosystems are particularly important, although inappropriate bioprospecting can increase biodiversity loss, as well as violating the laws of the communities and states from which the resources are taken.
If it is possible to answer this question, answer it for me (else, reply "unanswerable"): What percentage of US drugs are derived from synthetics?
Ah, so.. unanswerable

Northwestern was elected to the Association of American Universities in 1917 and remains a research university with "very high" research activity. Northwestern's schools of management, engineering, and communication are among the most academically productive in the nation. Northwestern received $550 million in research funding in 2014. Northwestern supports nearly 1,500 research laboratories across two campuses, predominately in the medical and biological sciences. Through the Innovation and New Ventures Office (INVO), Northwestern researchers disclosed 247 inventions, filed 270 patents applications, received 81 foreign and US patents, started 12 companies, and generated $79.8 million in licensing revenue in 2013. The bulk of revenue has come from a patent on pregabalin, a synthesized organic molecule discovered by chemistry professor Richard Silverman, which ultimately was marketed as Lyrica, a drug sold by Pfizer, to combat epilepsy, neuropathic pain, and fibromyalgia. INVO has been involved in creating a number of centers, including the Center for Developmental Therapeutics (CDT) and the Center for Device Development (CD2). It has also helped form over 50 Northwestern startup companies based on Northwestern technologies.
If it is possible to answer this question, answer it for me (else, reply "unanswerable"):  Who discovered the drug that was never marketed as Lyrica?
Ah, so.. unanswerable

The committee debated the possibility of a shift function (like in ITA2), which would allow more than 64 codes to be represented by a six-bit code. In a shifted code, some character codes determine choices between options for the following character codes. It allows compact encoding, but is less reliable for data transmission as an error in transmitting the shift code typically makes a long part of the transmission unreadable. The standards committee decided against shifting, and so ASCII required at least a seven-bit code.:215, 236 § 4
If it is possible to answer this question, answer it for me (else, reply "unanswerable"): What is different in a shifted code?
Ah, so..
some character codes determine choices between options for the following character codes